Jacques Theurillat
Chairman bij Vifor Pharma Management AG
Vermogen: 555 642 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Jacques Theurillat
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.
43
| Private Company | Investment Managers | 43 |
| Public Company | Trucks/Construction/Farm Machinery | 41 | |
CNH Global NV
 CNH Global NV Trucks/Construction/Farm MachineryProducer Manufacturing CNH Global NV is engaged in the manufacture, engineering, marketing and distribution of agricultural and construction equipment. Its brands include Case, New Holland, Case IH, and New Holland Construction. It operates through the following segments: Agricultural Equipment, Construction Equipment, and Financial Services. The Agricultural Equipment segment manufactures and distributes agricultural machineries such as two-wheel and four-wheel drive tractors, combines, cotton pickers, harvesters, hay tools, planting and seeding equipment, sprayer, and tillage equipment. The Construction Equipment segment offers excavators, crawler dozers, graders, wheel loaders, backhoe loaders, skid steer loaders, and trenchers. The Financial Services segment provides retail and wholesale financing and financing options. The company was founded on August 30, 1996 and is headquartered in Amsterdam, Netherlands.
31
| Extinct | Trucks/Construction/Farm Machinery | 31 |
| Public Company | Pharmaceuticals: Major | 29 | |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland.
20
| Extinct | Pharmaceuticals: Major | 20 |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Napp Pharmaceutical Holdings Ltd.
 Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.
15
| Private Company | Pharmaceuticals: Major | 15 |
Campus Holding SA
 Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland.
8
| Subsidiary | Investment Managers | 8 |
| Extinct | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jacques Theurillat via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree | |
| SGS SA | Miscellaneous Commercial Services | Chairman Chairman Director of Finance/CFO | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
Lawson Mardon Group Ltd.
 Lawson Mardon Group Ltd. Commercial Printing/FormsCommercial Services Part of Rio Tinto Ltd., Lawson Mardon Group Ltd. is a Canadian company that provides in-line rotogravure printed tobacco packaging and develops rotary cutting technology for the production of cigarette cartons. The private company is based in Toronto, Canada. Lawson Mardon Group was acquired by Alusuisse Lonza on November 01, 1993 for $432.80 million. | Commercial Printing/Forms | Director of Finance/CFO Human Resources Officer Director of Finance/CFO | |
Napp Pharmaceuticals Ltd.
 Napp Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceuticals Ltd. manufactures and wholesales pharmaceutical products. It offers analgesic, oncology and respiratory products and provides oral, transdermal, and parenteral delivery of products. The company was founded in 1923 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| TÜRK TRAKTÖR VE ZIRAAT MAKINELERI | Trucks/Construction/Farm Machinery | Director/Board Member Director/Board Member Director of Finance/CFO | |
| New York University | College/University | Graduate Degree Masters Business Admin | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
| University of St. Gallen | College/University | Undergraduate Degree Undergraduate Degree | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Bocconi | College/University | Undergraduate Degree Corporate Officer/Principal Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Director/Board Member Public Communications Contact | |
National Association of Manufacturers
 National Association of Manufacturers Miscellaneous Commercial ServicesCommercial Services The National Association of Manufacturers is an organization that works for the success of over 12.9 million people who are involved in manufacturing. The non-profit company is based in Washington and has subsidiaries in the United States. The American company's work is based on four core values that drive the industry. The company commissioned a study in August 2015, which found that the EPA's proposed ozone rule could reduce GDP by $140 billion. The CEO of the company is Jay Timmons. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Turin | College/University | Undergraduate Degree Undergraduate Degree | |
ADC Products (UK) Ltd.
 ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Founder Director/Board Member Director/Board Member | |
FCA US LLC
 FCA US LLC Motor VehiclesConsumer Durables FCA US LLC engages in the design, engineering, manufacture, distribution, and sale of vehicles. The company was founded on May 22, 2009 and is headquartered in South Lyon, MI. | Motor Vehicles | Chief Executive Officer Director/Board Member Director/Board Member Director of Finance/CFO | |
OM Pharma SA
 OM Pharma SA Pharmaceuticals: MajorHealth Technology OM Pharma SA engages in manufacture of pharmaceutical products. Its portfolio includes products for respiratory tract infections, lower urinary tract infections, chronic venous insufficiency, microangiopathies, hemorrhoids, and menometrorrhagia. The company was founded by Jean-Rene Ricard in 1937 and is headquartered in Meyrin, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Mundipharma GmbH (Germany)
 Mundipharma GmbH (Germany) Pharmaceuticals: MajorHealth Technology Mundipharma GmbH is one of the leading mid-sized pharmaceutical companies in Germany, has specialized successfully in the treatment of pain. Additional areas of research-based company are the areas of oncology and respiratory. The positive performance is reflected very clearly reflected in revenue and company size. The company was founded in 1967 and is headquartered in Limburg an der Lahn, Germany | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Napp Laboratories Ltd.
 Napp Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Napp Laboratories Ltd. wholesales pharmaceutical goods. It offers medicines for respiratory disease. The company was founded on September 26, 1923 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Napp Pharmaceutical Group Ltd.
 Napp Pharmaceutical Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Napp Pharmaceutical Holdings Ltd., Napp Pharmaceutical Group Ltd. is a British company founded in 1966 that brings medicines to the NHS. The private company is based in Cambridge, UK. Napp prides itself on earning the trust and respect of its customers by doing things the right way, not just with the quality of its products, but also with the friendly professionalism of its people. Napp Pharmaceuticals is a member of the network of independent associated companies. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Bard Pharmaceuticals Ltd.
 Bard Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Napp Pharmaceutical Holdings Ltd., Bard Pharmaceuticals Ltd. is a production and supply chain business that manufactures, packs, and supplies specialized medicines to help manage pain and other disease areas. The private company was founded in 1966 and is based in Cambridge, UK. Bard Pharmaceuticals is at the forefront of controlled release technology and produces medicines using the Continus® system, a prolonged release technology that has been combined with a variety of existing, effective medicines to bring additional benefits to patients. The British company is part of a broader network of independently associated companies that have a presence in 33 countries across Europe, Asia, and others throughout the rest of the world. Bard Pharmaceuticals is committed to providing people with the best available options to achieve a healthier lifestyle and offers lifestyle initiatives such as subsidized gym membership, healthy menu choices, and health advice available from on-site occupational health nurses. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MD Start SA
 MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France. | Biotechnology | Chairman Director/Board Member Chief Investment Officer | |
HighLife SAS
 HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Microphyt SA
 Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Biotechnology | Director/Board Member Director/Board Member | |
Mundipharma IT Services Ltd.
 Mundipharma IT Services Ltd. Information Technology ServicesTechnology Services Founded in 1952, Part of Mundipharma IT Services GmbH, Mundipharma IT Services Ltd. provides information technology services. The private company is based in Cambridge, UK. | Information Technology Services | Director/Board Member Director/Board Member | |
| FERRARI N.V. | Motor Vehicles | Chief Executive Officer Director/Board Member | |
EnobraQ SAS
 EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
Mundibiopharma Ltd.
 Mundibiopharma Ltd. Medical DistributorsDistribution Services Mundibiopharma Ltd. is a British pharmaceutical company that supplies pharmaceutical products. The private company is based in Cambridge, UK and was founded in 2014. | Medical Distributors | Director/Board Member Director/Board Member Director/Board Member | |
Mundipharma Medical Co. Ltd.
 Mundipharma Medical Co. Ltd. Medical DistributorsDistribution Services Part of Mundipharma International Ltd., Mundipharma Medical Co. Ltd. is a British company founded in 2014 that specializes in wholesale distribution of pharmaceutical goods. The private company is based in Cambridge, UK. | Medical Distributors | Director/Board Member Director/Board Member Director/Board Member | |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Founder Director/Board Member | |
SafeHeal SAS
 SafeHeal SAS Medical SpecialtiesHealth Technology SafeHeal SAS develops anastomosis protection devices for improved patient recovery and reduced healthcare costs. The company is headquartered in Paris, France. | Medical Specialties | Chairman Director/Board Member President | |
May Health SAS
 May Health SAS Miscellaneous Commercial ServicesCommercial Services May Health SAS engages in the development of device for the treatment of polycystic ovary syndrome infertility. The company was founded in September 2017 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chairman Chairman Director/Board Member | |
| IVECO GROUP N.V. | Motor Vehicles | Director/Board Member Director/Board Member Chairman | |
Moon Surgical SAS
 Moon Surgical SAS Medical SpecialtiesHealth Technology Moon Surgical SAS is a French medical technology company that is creating a new category of robotic surgery. The company is based in Paris, France and is operated by renowned serial medical innovators and backed by leading venture capitalists. Its Maestro system enhances existing laparoscopic techniques and tools with new capabilities, benefiting the 93%% of patients who currently do not have access to minimally invasive robotic surgery. The CEO of the company is Anne Osdoit. | Medical Specialties | Director/Board Member Director/Board Member Chief Executive Officer | |
The Business Roundtable
 The Business Roundtable Miscellaneous Commercial ServicesCommercial Services The Business Roundtable advocates public policies that ensure economic growth. It considers public policy issues which contains groups like the construction users anti-inflation roundtable, a group devoted to containing construction costs; and the labor law study committee, made up of labor relations executives of major companies. The Business Roundtable was founded in 1972 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigd Koninkrijk | 14 |
| Frankrijk | 11 |
| Zwitserland | 10 |
| Verenigde Staten | 9 |
| Italië | 7 |
Sectoraal
| Health Technology | 22 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Consumer Durables | 5 |
| Distribution Services | 4 |
Operationeel
| Director/Board Member | 669 |
| Corporate Officer/Principal | 203 |
| Chairman | 189 |
| Independent Dir/Board Member | 113 |
| Chief Executive Officer | 87 |
Sterkste connecties
| Insiders | |
|---|---|
| Vagn Ove Sørensen | 61 |
| Sergio Marchionne | 57 |
| Antoine Papiernik | 48 |
| Joshua Makower | 37 |
| Stephen Evans-Freke | 34 |
| Thomas M. Rinderknecht | 34 |
| Maria Patrizia Grieco | 32 |
| Hubertus Mühlhäuser | 30 |
| Petros Kalantzis | 27 |
| David Ebsworth | 26 |
| Maina Bhaman | 26 |
| Denis Lucquin | 26 |
| Graziano Seghezzi | 26 |
| Gérard Hascoët | 25 |
| Stuart David Baker | 25 |
- Beurs
- Insiders
- Jacques Theurillat
- Bedrijfsconnecties
